PRESS RELEASE published on 03/21/2024 at 14:00, 1 year 8 months ago Gemina Labs Strategic Update: Focusing on Respiratory Infections and Strategic Partnerships Gemina Laboratories Ltd shares strategic update for 2024, focusing on revenue streams, partnerships, and new technologies for diagnostics. Company plans new protein production facility and market expansion Partnerships Gemina Laboratories Ltd Strategic Update Revenue Streams Protein Production Facility
BRIEF published on 03/19/2024 at 13:35, 1 year 8 months ago Gemina finalise un financement par billets convertibles de 910 000 $ Placement Privé Laboratoires Gémina Financement Par Billets Convertibles Technologie Des Biocapteurs Plateformes De Diagnostic
BRIEF published on 03/19/2024 at 13:35, 1 year 8 months ago Gemina Completes $910,000 Convertible Note Financing Private Placement Gemina Laboratories Convertible Note Financing Biosensor Technology Diagnostic Platforms
PRESS RELEASE published on 03/19/2024 at 13:30, 1 year 8 months ago Gemina Announces Closing of $910,000 Convertible Note Financing Gemina Laboratories Ltd. raises $910,000 through non-brokered private placement of unsecured convertible notes for general working capital and corporate purposes. Securities subject to holding period and outside Canada restrictions Private Placement Working Capital Securities Laws Gemina Laboratories Ltd. Unsecured Convertible Notes
PRESS RELEASE published on 11/06/2023 at 14:00, 2 years ago Gemina Labs Ltd Appoints Stifel as Financial Advisor
PRESS RELEASE published on 07/25/2023 at 14:00, 2 years 4 months ago Gemina Laboratories Announces Major Breakthrough in Environmentally Friendly Lateral Flow Test Design by Removing the Requirement for Nitrocellulose
PRESS RELEASE published on 06/15/2023 at 15:00, 2 years 5 months ago Gemina Laboratories to Participate in Poster Session at American Association of Clinical Chemistry Annual Scientific Meeting
PRESS RELEASE published on 06/05/2023 at 14:00, 2 years 5 months ago Gemina Laboratories and ReadyGo Diagnostics Achieve Mycobacterium Tuberculosis Diagnosis in Saliva
PRESS RELEASE published on 05/17/2023 at 15:15, 2 years 6 months ago Gemina Labs Antibody Immobilization Chemistry Platform Demonstrates Major Lateral Flow Assay Performance Improvement
PRESS RELEASE published on 03/27/2023 at 17:50, 2 years 8 months ago Gemina Laboratories to Host Investor Webinar on March 30, 2023
Published on 12/05/2025 at 02:35, 6 hours 42 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 8 hours 17 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 10 hours 12 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 10 hours 17 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 09:05, 12 minutes ago Transforming Football: IBM and Bayer 04 Leverkusen Use AI for Superior Game Analysis
Published on 12/05/2025 at 08:45, 32 minutes ago Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 32 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/05/2025 at 08:42, 35 minutes ago ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 30 novembre 2025
Published on 12/04/2025 at 18:14, 15 hours 2 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 15 hours 17 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025